Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

Boissel JP, Leizorovicz A, Picolet H, Peyrieux JC.

Am J Cardiol. 1990 Aug 1;66(3):251-60.

PMID:
2195860
2.

Efficacy of acebutolol after acute myocardial infarction (the APSI trial). The APSI Investigators.

Boissel JP, Leizorovicz A, Picolet H, Ducruet T.

Am J Cardiol. 1990 Sep 25;66(9):24C-31C.

PMID:
2220646
4.

A population-based analysis of the class effect of beta-blockers after myocardial infarction.

Rinfret S, Abrahamowicz M, Tu J, Humphries K, Eisenberg MJ, Richard H, Austin PC, Pilote L.

Am Heart J. 2007 Feb;153(2):224-30.

PMID:
17239680
5.

Relevance of intrinsic sympathomimetic activity for beta blockers.

Jaillon P.

Am J Cardiol. 1990 Sep 25;66(9):21C-23C. Review.

PMID:
1977302
6.

[Hemodynamic effects of intravenous acebutolol in the acute phase of myocardial infarction].

Metzger JP, Montgermont P, N'Koua JL, Baubion N, Adams C, Meilhac B, Le Pailleur C, Vacheron A.

Ann Cardiol Angeiol (Paris). 1985 Jun;34(6):377-80. French.

PMID:
4026163
7.

Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.

Liu L; Chinese Cardiac Study (CCS-I) Collaborative Group.

Chin Med J (Engl). 2001 Feb;114(2):115-8.

PMID:
11780187
8.

Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.

Hioki H, Motoki H, Izawa A, Kashima Y, Miura T, Ebisawa S, Tomita T, Miyashita Y, Koyama J, Ikeda U.

Heart Vessels. 2016 May;31(5):687-93. doi: 10.1007/s00380-015-0673-1. Epub 2015 Apr 12.

9.

Cardioselective beta-blocker use in patients with reversible airway disease.

Salpeter S, Ormiston T, Salpeter E.

Cochrane Database Syst Rev. 2001;(2):CD002992. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD002992.

PMID:
11406056
10.

Circulatory effects of intravenous and oral acebutolol in acute myocardial infarction.

Silke B, Nelson G, Verma SP, Clarke J, Baliga G, Taylor SH.

Clin Pharmacol Ther. 1985 Sep;38(3):266-72.

PMID:
4028620
11.

Low-dose acebutolol given once daily in the treatment of chronic angina pectoris.

Piña IL, Smith EV, Weidler DJ.

J Clin Pharmacol. 1988 May;28(5):427-30.

PMID:
3392240
12.

Acebutolol effects on lipid profile.

Schnaper HW.

Am J Cardiol. 1990 Sep 25;66(9):49C-54C. Review. Erratum in: Am J Cardiol 1990 Dec 1;66(19):A8.

PMID:
2220651
13.

Intravenous acebutolol raises serum potassium in acute myocardial infarction.

Jardine RM, Obel IW, Smith AM.

Eur Heart J. 1986 Feb;7(2):140-5.

PMID:
3699050
14.

Cardioselective beta-blockers for reversible airway disease.

Salpeter S, Ormiston T, Salpeter E.

Cochrane Database Syst Rev. 2002;(1):CD002992. Review. Update in: Cochrane Database Syst Rev. 2002;(4):CD002992.

PMID:
11869646
16.

Effects of acebutolol on myocardial infarct extension: a randomized electrocardiographic, enzymatic and angiographic study.

Azancot I, Lorente P, Georgiopoulos G, Beaufils P, Masquet C, Baudouy Y, Slama R.

Circulation. 1982 Nov;66(5):986-94.

PMID:
6127172
18.

Suppression of premature ventricular contractions by acebutolol.

Gradman AH, Winkle RA, Fitzgerald JW, Meffin PJ, Stoner J 3rd, Bell PA, Harrison DC.

Circulation. 1977 May;55(5):785-91.

PMID:
66105
19.

Beta-blocker underuse in secondary prevention of myocardial infarction.

Everly MJ, Heaton PC, Cluxton RJ Jr.

Ann Pharmacother. 2004 Feb;38(2):286-93. Epub 2003 Dec 30. Review.

PMID:
14742768

Supplemental Content

Support Center